Literature DB >> 11083819

Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.

L G Bekker1, A L Moreira, A Bergtold, S Freeman, B Ryffel, G Kaplan.   

Abstract

In experimental mycobacterial infection, tumor necrosis factor alpha (TNF-alpha) is required for control of bacillary growth and the protective granulomatous response, but may cause immunopathology. To directly examine the positive and detrimental effects of this cytokine, a murine model was used in which different amounts of TNF-alpha were delivered to the site of infection. Mice with a disruption in the TNF-alpha gene (TNF-KO) or wild-type mice were infected with low or high doses of recombinant Mycobacterium bovis BCG that secreted murine TNF-alpha (BCG-TNF). Infection of TNF-KO mice with BCG containing the vector (BCG-vector) at a low dose led to increased bacillary load in all organs and an extensive granulomatous response in the lungs and spleen. The mice succumbed to the infection by approximately 40 days. However, when TNF-KO mice were infected with low doses of BCG-TNF, bacillary growth was controlled, granulomas were small and well differentiated, the spleen was not enlarged, and the mice survived. Infection with high inocula of BCG-TNF resulted in bacterial clearance, but was accompanied by severe inflammation in the lungs and spleen and earlier death compared to the results from the mice infected with high inocula of BCG-vector. Wild-type mice controlled infection with either recombinant strain, but showed decreased survival following high-dose BCG-TNF infection. The effects of TNF-alpha required signaling through an intact receptor, since the differential effects were not observed when TNF-alpha receptor-deficient mice were infected. The results suggest that the relative amount of TNF-alpha at the site of infection determines whether the cytokine is protective or destructive.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083819      PMCID: PMC97804          DOI: 10.1128/IAI.68.12.6954-6961.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo.

Authors:  D R Roach; H Briscoe; K Baumgart; D A Rathjen; W J Britton
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 2.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

Authors:  A G Bean; D R Roach; H Briscoe; M P France; H Korner; J D Sedgwick; W J Britton
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

4.  Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages.

Authors:  M Denis; E O Gregg; E Ghandirian
Journal:  Int J Immunopharmacol       Date:  1990

5.  TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.

Authors:  R Josien; B R Wong; H L Li; R M Steinman; Y Choi
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

6.  Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.

Authors:  A L Moreira; L Tsenova; P J Murray; S Freeman; A Bergtold; L Chiriboga; G Kaplan
Journal:  Microb Pathog       Date:  2000-09       Impact factor: 3.738

7.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

Authors:  W J Ming; L Bersani; A Mantovani
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

8.  Possible roles of tumor necrosis factor in the pathology of malaria.

Authors:  I A Clark; W B Cowden; G A Butcher; N H Hunt
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

9.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

10.  The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.

Authors:  G Kaplan; A D Luster; G Hancock; Z A Cohn
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  72 in total

Review 1.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

3.  Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA.

Authors:  Jennifer L Taylor; Diane J Ordway; Jolynn Troudt; Mercedes Gonzalez-Juarrero; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

5.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

6.  Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.

Authors:  Wen-Lin Su; Wann-Cherng Perng; Ching-Hui Huang; Cheng-Yu Yang; Chin-Pyng Wu; Jenn-Han Chen
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

7.  Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase.

Authors:  Nisheeth Agarwal; Gyanu Lamichhane; Radhika Gupta; Scott Nolan; William R Bishai
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

8.  Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits.

Authors:  Susan E Dorman; Christine L Hatem; Sandeep Tyagi; Katherine Aird; Javier Lopez-Molina; M Louise M Pitt; Bernard C Zook; Arthur M Dannenberg; William R Bishai; Yukari C Manabe
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment.

Authors:  James M Young; Ifedayo M O Adetifa; Martin O C Ota; Jayne S Sutherland
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

10.  Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.

Authors:  Nasiema Allie; Lena Alexopoulou; Valerie J F Quesniaux; Lizette Fick; Ksanthi Kranidioti; George Kollias; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunology       Date:  2008-06-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.